Literature DB >> 1621977

Recombination and amplification of multiple portions of genomic DNA by a modified polymerase chain reaction.

K Uchida1.   

Abstract

A novel method, a modified polymerase chain reaction (mPCR), is reported for in vitro recombination and amplification of two or more regions of DNA located in distinct parts of a genome such as exons of a gene. The reaction consists of three stages. In the first stage, the portions are amplified individually with the aid of four or more primers. Of the primers, two (outside primers) are complementary to 3'-terminal parts of the objective, recombinant DNA, and the others (inside primers) are complementary to 3'-terminal parts of the other portions. Some of the inside primers have extra nucleotide sequences at their 5'-termini which are complementary to 5'-terminal parts of the portions to be recombined. In the second stage, the strands with complementary sequences in their 3'-terminal parts are annealed sequentially to one another and are converted to recombinant DNA with DNA polymerase. In the final stage, the objective DNA is amplified with the excess outside primers. The application of this method for in vitro recombination and amplification of three exons of the gene for human muscle-specific phosphoglycerate mutase is described.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1621977     DOI: 10.1016/0003-2697(92)90221-r

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  4 in total

1.  Troubleshooting in gene splicing by overlap extension: a step-wise method.

Authors:  F J Mergulhão; A G Kelly; G A Monteiro; M A Taipa; J M Cabral
Journal:  Mol Biotechnol       Date:  1999-10       Impact factor: 2.695

2.  A transgenic mouse model engineered to investigate human brain-derived neurotrophic factor in vivo.

Authors:  Fabrice Guillemot; Italina Cerutti; Charles Auffray; Marie-Dominique Devignes
Journal:  Transgenic Res       Date:  2007-01-16       Impact factor: 2.788

3.  Development and prevention of advanced diabetic nephropathy in RAGE-overexpressing mice.

Authors:  Y Yamamoto; I Kato; T Doi; H Yonekura; S Ohashi; M Takeuchi; T Watanabe; S Yamagishi; S Sakurai; S Takasawa; H Okamoto; H Yamamoto
Journal:  J Clin Invest       Date:  2001-07       Impact factor: 14.808

4.  An enzyme-linked immunosorbent assay and reference ranges for bisphosphoglycerate mutase in human erythrocytes.

Authors:  T Takubo; I Tsuda; N Tatsumi; K Kasuya; Y Taniguchi; T Fujita; K Uchida; Y Matsuo; T Hayashi
Journal:  J Clin Lab Anal       Date:  1998       Impact factor: 2.352

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.